Urinalysis, but Not Blood Biochemistry, Detects the Early Renal Impairment in Patients with COVID-19.
Haifeng ZhouZili ZhangMaria DobrininaYalan DongZhenyu KangValerii ChereshnevDesheng HuZhe ZhangJun ZhangAlexey P SarapultsevPublished in: Diagnostics (Basel, Switzerland) (2022)
Kidney impairment is prevalent among COVID-19 patients, with an abnormal urinalysis as a clinical manifestation, implying that a routine urine test is a stronger indication of prospective kidney complication than a blood biochemistry test.